{"id":2185,"date":"2015-08-20T05:01:28","date_gmt":"2015-08-20T05:01:28","guid":{"rendered":"http:\/\/nsbri.org\/?page_id=2185"},"modified":"2016-02-08T14:18:31","modified_gmt":"2016-02-08T14:18:31","slug":"medical-advances","status":"publish","type":"page","link":"http:\/\/nsbri.org\/impact\/medical-advances\/","title":{"rendered":"Medical Advances"},"content":{"rendered":"

[vc_row row_fullwidth=”0″ header=”0″][vc_column width=”1\/4″][vc_column_text]<\/p>\n

For Space & Earth<\/h2>\n

[\/vc_column_text][\/vc_column][vc_column width=”3\/4″][vc_column_text]<\/p>\n

CNS & Ophthalmic Diagnostic Capabilities<\/h2>\n

The Institute conducted the first independent clinical test of the Vittamed device for noninvasive assessment of intracranial pressure. The results in normal subjects and patients were significant, and NSBRI worked with the manufacturer to make improvements to address NASA\u2019s needs. The device is being considered for operational use by NASA, and it also has applications in neurology and neurosurgery, where invasive measurement of intracranial pressure is one of the most commonly performed procedures.<\/p>\n

New Uses for Ultrasound<\/h2>\n
\"Dr.<\/a>

Dr. Scott A. Dulchavsky views an image of a surgical procedure being performed remotely by a non-physician on the NASA Microgravity Research Facility. He uses just-in-time training, combined with voice commands, to guide a minimally trained operator to perform complex procedures in space or on the ground. Photo by NASA.<\/p><\/div>\n

The Institute collaborated with NASA and industry to advance ultrasound training and diagnostic medical imaging aboard the International Space Station (ISS). NSBRI subsequently supported the development of an ultrasound catalog for ISS autonomous care, obviating the need for an emergency return to Earth, which would cost more than $200 million.<\/p>\n

Scientists supported by NSBRI developed scanning confocal pulsed ultrasound to successfully assess and improve bone mineral density, structural integrity, and trabecular strength. They also showed that the technology can be made portable, enhance fracture healing, and reduce disuse-related bone loss. These advances are relevant to use in space, as well as on Earth, where there are an estimated 10 million Americans \u2013 80 percent of them female \u2013 who have osteoporosis, and another 34 million who have significantly reduced bone mass (i.e., osteopenia).<\/p>\n

NSBRI conducted the first-in-human trial of non-invasively moving and clearing kidney stones. The technology, developed by NSBRI-funded engineers, may transform urological practice. Astronauts are at increased risk of kidney stone formation, and 14 have experienced stones post-flight. The prevalence of kidney stones is 5% in the United States, and increasing worldwide, with associated rising costs \u2013 greater than $2 billion in health care and greater than $3 billion in workdays lost per annum in the United States.<\/p>\n

Tools for Measuring Cognitive Abilities<\/h2>\n
\"During<\/a>

During NEEMO 12, veteran astronaut Heidemarie Stefanyshyn-Piper is shown with a Psychomotor Vigilance Test (PVT) Self Test device. Photo by NASA.<\/p><\/div>\n

NSBRI led research to develop and employ the Psychomotor Vigilance Task (PVT), an objective assessment tool of psychomotor performance, which has become a cornerstone of NASA\u2019s behavioral health program. The Institute conducted studies in analog environments and aboard the ISS to characterize individual susceptibilities and differences, and inform countermeasure development and requirements. The U.S. Department of Transportation relied on NSBRI-supported PVT research methods to set regulations improving truck driver health and safety, with the aim of reducing fatal tractor trailer accidents costing lives and more than $20 billion annually.\u00a0An NSBRI operational deliverable is replacing dated neurocognitive assessments of astronauts during flight. A new cognitive test battery was evaluated in space analogs and has been in use aboard the ISS since 2014. High levels of cognitive performance, and unobtrusive ways to rapidly assess metrics without interfering with a mission, are important for human space exploration and other critical job areas.<\/p>\n

Heart and Cardiovascular Disease Risk Prediction<\/h2>\n
\"ASTROCHARM<\/a>

The Astro-CHARM tool uses demographic and medical data to calculate risk of cardiovascular disease in people who display no symptoms<\/p><\/div>\n

The Astro-CHARM (Cardiovascular Health and Risk Modification) project is developing a tool for determining an asymptomatic individual\u2019s cardiovascular risk. It\u00a0 includes well-established risk factors like age, sex, history of cardiovascular events, use of cholesterol-lowering medications, and coronary calcium scores, all combined into a weighted and validated tool that can be used to estimate likelihood of events or to recommend that individuals take steps to reduce their risk.<\/p>\n

<\/h2>\n

<\/h2>\n

<\/h2>\n

Sleep and Lighting<\/h2>\n
\"A<\/a>

A study subject undergoes Ganzfeld exposure to monochromatic blue light at Jefferson Medical College of Thomas Jefferson University. The goal of this project is to provide lighting in spaceflight that improves the sleep and biological rhythms of astronauts.<\/p><\/div>\n

NSBRI supported groundbreaking fundamental and applied research demonstrating the effectiveness of blue-enriched light to entrain circadian rhythms. Subsequent NSBRI-funded studies on sleep-wake alterations and performance using blue-enriched light as a potential operational countermeasure led to positive results that were paramount in NASA\u2019s decision to install new solid state LED lighting with blue spectrum capabilities aboard the ISS.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator border_width=”2″][\/vc_column][\/vc_row][vc_row row_fullwidth=”0″ header=”0″][vc_column width=”1\/4″][\/vc_column][vc_column width=”3\/4″][vc_column_text]<\/p>\n

Related News<\/h2>\n

Space institute to fund electronic adjustable power eyeglasses and a smart sleep mask<\/a><\/p>\n

Trial to test using ultrasound to move kidney stones<\/a>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row row_fullwidth=”0″ header=”0″][vc_column width=”1\/4″][vc_column_text] For Space & Earth [\/vc_column_text][\/vc_column][vc_column width=”3\/4″][vc_column_text] CNS & Ophthalmic Diagnostic Capabilities The Institute conducted the first independent clinical test of the Vittamed device for noninvasive assessment of intracranial pressure. The results in normal subjects and patients were significant, and NSBRI worked with the manufacturer to make improvements to address NASA\u2019s needs. […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":67,"menu_order":0,"comment_status":"open","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"http:\/\/nsbri.org\/wp-json\/wp\/v2\/pages\/2185"}],"collection":[{"href":"http:\/\/nsbri.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/nsbri.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/nsbri.org\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/nsbri.org\/wp-json\/wp\/v2\/comments?post=2185"}],"version-history":[{"count":24,"href":"http:\/\/nsbri.org\/wp-json\/wp\/v2\/pages\/2185\/revisions"}],"predecessor-version":[{"id":21704,"href":"http:\/\/nsbri.org\/wp-json\/wp\/v2\/pages\/2185\/revisions\/21704"}],"up":[{"embeddable":true,"href":"http:\/\/nsbri.org\/wp-json\/wp\/v2\/pages\/67"}],"wp:attachment":[{"href":"http:\/\/nsbri.org\/wp-json\/wp\/v2\/media?parent=2185"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}